MY145068A - Imidazole compounds for the treatment of neurodegenerative disorders - Google Patents

Imidazole compounds for the treatment of neurodegenerative disorders

Info

Publication number
MY145068A
MY145068A MYPI20051245A MY145068A MY 145068 A MY145068 A MY 145068A MY PI20051245 A MYPI20051245 A MY PI20051245A MY 145068 A MY145068 A MY 145068A
Authority
MY
Malaysia
Prior art keywords
treatment
neurodegenerative disorders
imidazole compounds
compounds
formula
Prior art date
Application number
Inventor
Michael Aaron Brodney
Karen Jean Coffman
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to MYPI20051245 priority Critical patent/MY145068A/en
Publication of MY145068A publication Critical patent/MY145068A/en

Links

Abstract

THE PRESENT INVENTION RELATES TO COMPOUNDS OF THE FORMULA 1 WHEREIN R¹, R ², R³, R⁴, R⁶, R⁷ AND A ARE AS DEFINED. COMPOUNDS OF THE FORMULA 1 HAVE ACTIVITY INHIBITING PRODUCTION OF Aβ-PEPTIDE. THE INVENTION ALSO RELATES TO PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS, FOR EXAMPLE, NEURODEGENERATIVE AND/OR NEUROLOGICAL DISORDERS, E.G., ALZHEIMER'S DISEASE, IN A MAMMAL COMPRISING COMPOUNDS OF THE FORMULA 1.
MYPI20051245 2005-03-22 2005-03-22 Imidazole compounds for the treatment of neurodegenerative disorders MY145068A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20051245 MY145068A (en) 2005-03-22 2005-03-22 Imidazole compounds for the treatment of neurodegenerative disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20051245 MY145068A (en) 2005-03-22 2005-03-22 Imidazole compounds for the treatment of neurodegenerative disorders

Publications (1)

Publication Number Publication Date
MY145068A true MY145068A (en) 2011-12-15

Family

ID=45444848

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20051245 MY145068A (en) 2005-03-22 2005-03-22 Imidazole compounds for the treatment of neurodegenerative disorders

Country Status (1)

Country Link
MY (1) MY145068A (en)

Similar Documents

Publication Publication Date Title
UA83899C2 (en) Imidazole compounds for the treatment of neurodegenerative disorders
MY136718A (en) Sulfonamide compounds for the treatment of neurodegenerative disorders
TW200420550A (en) Thiazole compounds for the treatment of neurodegenerative disorders
CA2534532A1 (en) Compounds for the treatment of neurodegenerative disorders
BR0315158A (en) Pyrazole Compounds for the Treatment of Neurodegenative Disorders
TW200745135A (en) Therapeutic agents
EA200800975A1 (en) Pyrimidinylamide Compounds (Variants) Including Their Pharmaceutical Composition and Method for the Treatment of Disorder Mediated by α4-Integrin
BRPI0509504A (en) thiadiazole amine compounds for the treatment of neurodegenerative disorders
MXPA05012196A (en) Isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders.
WO2005011601A3 (en) 6-menbered heteroaryl compounds for the treatment of neurodegenerative disorders
TW200635589A (en) Therapeutic agents
WO2005095348A3 (en) Pyrazole-amine compounds for the treatment of neurodegenerative disorders
TW200734324A (en) Therapeutic agents
WO2007034326A3 (en) Imidazole compounds for the treatment of neurological disorders
WO2005097114A3 (en) Thiazole sulfonamide compounds for the treatment of neurodegenerative disorders
MX2010002765A (en) 6-pyrimidinyl-pyrimid-2-one derivative.
BRPI0509582A (en) thiazol amine compounds and their pharmaceutical compositions
WO2005016267A3 (en) Oxazole compounds for the treatment of neurodegenerative disorders
WO2005095361A8 (en) Isoxazole- and isothiazole-amine compounds for the treatment of neurodegenerative disorders
MY145068A (en) Imidazole compounds for the treatment of neurodegenerative disorders
PL2123328T3 (en) Galanthamine derivatives, methods for their obtaining and use
DOP2004000982A (en) COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
EA200500382A1 (en) TIAZOLE CONNECTIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
CU23591B7 (en) IMIDAZOL COMPOUNDS FOR THE TREATMENT OF NEUROVEGETATIVE DISORDERS